A Health Ministry study has confirmed there is no benefit in repurposing the antiparasitic drug ivermectin to treat Covid-19, in line with high-quality studies published on the matter.

Instead, study participants who received ivermectin were three times more likely to report side effects compared to participants who didn’t – usually cases of diarrhoea...